New HIV biomarker identified; Disrupted micronuclei may help diagnose cancer;

> A new study has identified the protein thrombospondin as an HIV biomarker. Story

> Duke Medicine developed a blood test that relies on 60 co-expressed genes to help predict the success of aspirin treatments for cardiac patients. Story

> Salk Institute scientists believe that disrupted micronuclei could serve as a viable biomarker for a number of cancers. Item

> Switzerland's Debiopharm inked a one-year deal to focus on new biomarker discovery. Story

> Patients with low-IQ autism and intellectual disabilities appear to have DNA markers that suggest their conditions are hereditary. Release

Suggested Articles

Sherlock Biosciences teamed up with Cepheid to help develop its CRISPR-based molecular diagnostic tech in oncology, infections and the coronavirus.

The spine surgery company ATEC has moved to acquire Paris-based EOS imaging, makers of FDA-cleared scanners and 3D orthopedic planning software.

Digital molecule designer Insilico Medicine has launched a new preclinical research program focused on treatments for brain cancer.